Index Ventures

Activity from announced rounds

Activity in this selectionUndisclosed

Index Ventures invests across technology sectors from seed through venture and growth, with teams in San Francisco, New York and London.

The firm publishes practical research for founders through Index Press. Its resources address three distinct scaling decisions: structuring employee stock options, building an organisation as headcount expands and entering the US market.

OptionPlan, TeamPlan and ExpansionPlan accompany the research with planning tools. These resources are particularly useful when fundraising is tied to hiring, opening a US operation or redesigning compensation as a company moves beyond its founding team.

Sources
Rounds participated in
7
Confirmed lead rounds
2
2 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$1.7B
7 disclosed · full round size, not this investor’s share

By stage

Undisclosed7

By primary sector

AI2
Enterprise software2
Healthtech2
Fintech1

By country

United States3
France2
Finland1
United Kingdom1

Rounds

7 in this selection
Opply

An operating platform that helps consumer goods brands run sourcing, procurement and supply-chain work.

$7.5MUndisclosed
Participant
Allara

Virtual care for women with hormonal, metabolic and reproductive health needs.

$30MFunding
Participant
Ando

Ando provides team messaging where people and AI agents share conversations and working context.

$20MCombined pre-seed and seed
Lead
Thatch

A health-benefits platform that lets employers set healthcare budgets while employees choose insurance and eligible care to fit their needs.

$108MNew funding
Participant
Qutwo

Builds Qutwo OS, a software platform helping companies leverage AI as quantum computing develops

€25MAngel
Role not disclosed
Alan

Alan combines health insurance, preventive services and access to care in a digital platform for employers and members.

€100MFunding
Lead
Mistral AI

Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.

€1.2BStrategic
Role not disclosed